Company No: 10640484 (England and Wales)

Contents

• Company Information
• Statement of Financial Position
• Notes to the Financial Statements

DIRECTOR	J A Ford
	M R Sorrell (Resigned 25 September 2024)

REGISTERED OFFICE	Unit D
	Crondall Place Coxbridge Business Park
	Alton Road
	Farnham
	GU10 5EH
	United Kingdom

COMPANY NUMBER

10640484 (England and Wales)

ACCOUNTANT	Shaw Gibbs Limited
	Wey Court West
	Union Road
	Farnham
	Surrey
	GU9 7PT

	Note	2025		2024
		£		£
Current assets
Debtors	3	3,139		4,912
Cash at bank and in hand		30,628		30,744
		33,767		35,656
Creditors: amounts falling due within one year	4	( 3,546)		( 3,806)
Net current assets		30,221		31,850
Total assets less current liabilities		30,221		31,850
Net assets		30,221		31,850
Capital and reserves
Called-up share capital	5	95		100
Profit and loss account		30,126		31,750
Total shareholders' funds		30,221		31,850

For the financial year ending 28 February 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
• These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Statement of Income and Retained Earnings has not been delivered.

The financial statements of UK Rep Med Limited (registered number: 10640484) were approved and authorised for issue by the Director on 10 September 2025. They were signed on its behalf by:

J A Ford Director

1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

UK Rep Med Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Unit D, Crondall Place Coxbridge Business Park, Alton Road, Farnham, GU10 5EH, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Turnover from the supply of services represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the fair value of the consideration received or receivable. Where a contract has only been partially completed at the Statement of Financial Position date turnover represents the fair value of the service provided to date based on the stage of completion of the contract activity at the Statement of Financial Position date. Where payments are received from customers in advance of services provided, the amounts are recorded as deferred income and included as part of creditors due within one year.

Taxation

Current tax
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Trade and other debtors

Trade and other debtors are recognised at transaction price less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are recognised at transaction price.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

The company only operates basic financial instruments.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

	2025		2024
	Number		Number
Monthly average number of persons employed by the Company during the year, including the director	3		1

3. Debtors

	2025		2024
	£		£
Trade debtors	2,660		0
Prepayments	265		3,544
VAT recoverable	119		121
Corporation tax	0		1,147
Other debtors	95		100
	3,139		4,912

4. Creditors: amounts falling due within one year

	2025		2024
	£		£
Trade creditors	469		101
Accruals	1,215		950
Taxation and social security	1,862		782
Other creditors	0		1,973
	3,546		3,806

5. Called-up share capital

	2025		2024
	£		£
Allotted, called-up and fully-paid
35 A ordinary shares of £ 1.00 each	35		35
35 C ordinary shares of £ 1.00 each	35		35
25 D ordinary shares of £ 1.00 each	25		25
Nil B ordinary shares (2024: 5 shares of £ 1.00 each)	0		5
	95		100